Skip to content Skip to navigation

Designing Solutions for Maternal and Infant Health

2015 Conference Speakers

Thank you to all our speakers who's engaging presentations made the inaugural Childx conference a success. View the complete list of speakers below.


  • Alan Cheng, MD

    Alan Cheng, MD

    Alan Cheng joined the Department of Otolaryngology-Head and Neck Surgery at Stanford University as a surgeon-scientist in 2007.  His clinical practice based at the Stanford Ear Institute and Lucile Packard Children’s Hospital focuses on otologic diseases including congenital hearing loss and cochlear implantation in children.  In parallel, his research program focuses on inner ear hair cell development and regeneration. He has received funding from the NIH, the Department of Defense, the American Otological Society, and California Institute for Regenerative Medicine for this research endeavor.

  • Christopher Longhurst, MD

    Christopher Longhurst, MD

    Dr. Christopher Longhurst is a board-certified hospitalist at Lucile Packard Children’s Hospital and an Associate Professor of Clinical Pediatrics and Biomedical Informatics at the Stanford University School of Medicine. Chris also has a graduate degree in medical informatics and holds an administrative appointment as the Chief Medical Information Officer at Stanford Children’s Health. In this role he has helped lead the hospital’s transition to electronic medical records and developed that system as a diverse tool to enhance patient safety, efficiency, and quality of care.

  • Hugh O'Brodovich, MD, FRCP(C)

    Hugh O’Brodovich, MD, FRCP(C)

    Stanford Medicine/Pediatrics

    Dr. O’Brodovich assumed the positions of Chair of the Department of Pediatrics at Stanford University School of Medicine and the Adalyn Jay Physician in Chief at Lucile Packard Children's Hospital in January 2008. In 2010 he was appointed as the inaugural Director of the Stanford Child Health Research Institute. His current research involves population-based studies to discover the genetic influences on the development of Bronchopulmonary dysplasia and the long term outcomes of neonatal lung disease. He currently serves on the Council of the American Pediatric Society and has published 168 peer-reviewed manuscripts and 21 book chapters.

  • Gary Shaw, PhD

    Gary M. Shaw, PhD

    Stanford Medicine/Pediatrics/Neonatology

    Dr. Shaw is Professor & Associate Chair of Pediatrics, Stanford University, where he has conducted epidemiologic research for 25 years. He is Co-PI of March of Dimes Prematurity Research Center, PI of California Center Finding Causes and Preventives of Birth Defects, and a PI for UC Berkeley/Stanford Children’s Environmental Health Center. Research interests include epidemiology of birth defects and gene-environment approaches to perinatal outcomes. He has published around 350 scientific papers.


  • David Stevenson, MD, PhD

    David Stevenson, MD

    Stanford Medicine/Pediatrics

    Dr. David K. Stevenson serves as the Principal Investigator for the March of Dimes Research Center at Stanford University.  He is the Harold K. Faber Professor of Pediatrics and has held numerous leadership roles at Stanford University School of Medicine.  He is currently the Senior Associate Dean for Maternal & Child Health, the Director of the Charles B. and Ann L. Johnson Center for Pregnancy and Newborn Services, the Co-Director of the Stanford Child Health Research Institute, and the Leader of Spectrum Child Health at Stanford University.

    Dr. Stevenson has received many awards, including the Virginia Apgar Award, which is the highest award in Perinatal Pediatrics, and the Jonas Salk Award for Leadership in Prematurity Prevention from the March of Dimes Foundation.  In recognition of his achievements, Dr. Stevenson is a member of the National Academy of Medicine.  He has served as the President of the American Pediatric Society and was co-founder of the California Association of Neonatologists (CAN) and the California Perinatal Quality Care Collaborative (CPQCC).  Dr. Stevenson has published over 530 articles on a wide range of scientific topics in neonatal- perinatal medicine.  He is also the editor of several textbooks and numerous chapters in most of the major textbooks on neonatology.

  • Bonnie Whalen, MBA

    Bonnie Whalen, MBA

    Stanford Child Health Research Institute/LPCH

    Ms. Whalen is the Administrative Director, Stanford Child Health Research Institute, and Director, Children’s Health Initiative at Lucile Packard Children’s Hospital Stanford.  She facilitates strategic planning for the Institute to achieve alignment between academic and clinical priorities, and directs all business and financial activities.  Bonnie oversees the design and implementation of a variety of competitive award programs for faculty scholars, postdoctoral fellows, pilot studies, and transdisciplinary initiatives available to all child and maternal health investigators.

Special Presentation

  • Alan Guttmacher, MD

    Conference Keynote

    Alan E. Guttmacher, MD

    Permanent Fund for Vermont's Children

    Alan E. Guttmacher, M.D. is a pediatrician and medical geneticist who is Senior Advisor at the Permanent Fund for Vermont’s Children. From 2009-2015, he served as director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the focal point at the National Institutes of Health for research in pediatric health and development, maternal health, reproductive health, intellectual and developmental disabilities, and rehabilitation medicine, among other areas. Dr. Guttmacher came to NIH in 1999 to work at the National Human Genome Research Institute, where he served in a number of roles, including Deputy Director and Acting Director, thus overseeing that institute’s efforts to advance genome research, integrate that research into health care, and explore the ethical, legal, and social implications of human genomics.

    Among Dr. Guttmacher’s areas of expertise is the development of new approaches for translating genomics into better ways of diagnosing, treating, and preventing disease. A graduate of Harvard College and Harvard Medical School, he completed an internship and residency in Pediatrics and a fellowship in Medical Genetics at Harvard and Children’s Hospital of Boston. He is a member of the National Academy of Medicine.

  • Rajiv Shah, MD

    Conference Keynote

    Rajiv Shah, MD

    Georgetown University

    Dr. Rajiv Shah has been a tireless and dedicated leader, committed to advancing the missions of the United States Agency for International Development and the United States Department of Agriculture. Serving alongside some of the most innovative leaders in the world, navigating major natural disasters and man-made crises, Dr. Shah has successfully delivered results and lived up to USAID’s goal of partnering to end extreme poverty and to promote resilient, democratic societies while advancing security and prosperity.

  • Cristina Alvira, MD

    Cristina Alvira, MD

    Stanford/Pediatrics/Critical Care

    Dr. Alvira is an Assistant Professor of Pediatrics and an attending physician in the Pediatric Intensive Care Unit of Lucile Packard Children’s Hospital. Dr. Alvira’s research program is centered on understanding the molecular mechanisms that promote alveolarization, the final stage of lung development that occurs primarily after birth. Growth of the pulmonary vasculature by angiogenesis drives alveolarization, and specific work in the Alvira laboratory has identified novel angiogenic pathways in the postnatal lung. Current studies are aiming to exploit these pathways to develop new therapies to treat pediatric lung diseases characterized by impaired angiogenesis and alveolarization such as bronchopulmonary dysplasia, and to stimulate regenerative lung growth after injury.

  • Samuel Cheshier, MD, PhD

    Samuel Cheshier, MD, PhD

    Stanford/Neurosurgery/Pediatric Neurosurgery

    Dr. Cheshier is an Assistant Professor of Pediatric Neurosurgery.  His surgical practice includes a strong emphasis on pediatric tumors of the brain and spine.  Dr. Cheshier’s laboratory performs highly sophisticated, pediatric specific, preclinical animal studies in order to translate these findings into clinical trials in children with malignant brain tumors including medulloblastoma, pediatric glioblastoma, and diffuse intrinsic pontine glioma. His group is utilizing a monoclonal antibody to stimulate immune cell macrophages to specifically target and remove these brain cancers with an emphasis on removal of the cancer stem cells.

  • Mary Leonard, MD, MS

    Mary Leonard, MD, MS

    Stanford Medicine/Pediatrics & Medicine/Nephrology

    Dr. Leonard is a Professor of Pediatrics and Medicine and Co-Leader of Spectrum Child Health at Stanford. Her multidisciplinary research program is focused on the impact of childhood chronic diseases on bone quality and muscle function across the life course, with an emphasis on the effects of glucocorticoid therapy, inflammation and chronic kidney diseases. She has served in leadership roles on international committees to develop clinical practice guidelines for the assessment of bone health in children, and the management of metabolic bone disease in children and adults with chronic kidney disease.

Life Course from Fetal to Adult

  • Matthew Gillman, MD, SM

    Keynote Speaker

    Matthew Gillman, MD, SM


    Dr. Gillman is a Professor and Director of the Obesity Prevention Program in the Department of Population Medicine at Harvard Medical School. His research interests include early life prevention of chronic disease, including obesity, diabetes, cardiovascular disease, and asthma; individual and policy-level interventions to prevent obesity and its consequences; and childhood cardiovascular risk factors. He directs Project Viva, an NIH-funded cohort study of pregnant women and their offspring, focusing on effects of gestational diet and other factors on outcomes of pregnancy and childhood. He has served in leadership roles in the U.S. National Children's Study, the International Society for Developmental Origins of Health and Disease, the American Heart Association, and the American Academy of Pediatrics. 

  • michellemonje


    Michelle Monje, MD, PhD

    Stanford/Neurology/Child Neurology

    Dr. Monje is Assistant Professor of Neurology and Neuro-Oncology at Stanford University where she focuses on the molecular and cellular mechanisms of postnatal neurodevelopment. As a practicing neurologist and neuro-oncologist, she is particularly interested in the roles for neural precursor cell function and dysfunction in the origins of pediatric brain tumors and the consequences of cancer treatment.

  • Gabriel Corfas, PhD

    Gabriel Corfas, PhD


    Previously on the faculty at Harvard Medical School and Boston Children’s Hospital, Dr. Corfas recently joined the faculty of the University of Michigan, where he directs the Kresge Hearing Research Institute and is a Professor and Associate Chair for Research in the Department of Otolaryngology.

  • Sheena Josselyn, PhD

    Sheena Josselyn, PhD

    SickKids/U. Toronto

    Sheena Josselyn is a Senior Scientist at The Hospital for Sick Children (SickKids) and an Associate Professor at the University of Toronto.  She holds a Canada Research Chair in Molecular and Cellular Cognition.  Her work is dedicated to understanding the molecular, cellular and circuit processes underlying how the brain encodes, stores and uses information.

  • Don Mabbott, PhD

    Don Mabbott, PhD

    SickKids/U Toronto

    Dr. Mabbott is a Senior Scientist in the Research Institute of the Hospital for Sick Children and Associate Professor of Psychology at the University of Toronto evaluating brain/behaviour relations in normal and impaired neurodevelopment using cognitive data and quantitative MRI methods. He is currently examining neurocognitive outcomes following diagnosis and treatment with radiation for brain tumors and demonstrating that cranial radiation is associated with intellectual decline. He recently began exciting new work to find ways to foster brain repair following radiation injury in children treated for brain tumors, including using physical exercise and drugs that stimulate the growth of new brain cells.

  • Theo Palmer, PhD

    Theo Palmer, PhD


    Dr. Palmer’s lab at Stanford University focuses on the biology of neural stem cells in the developing and adult brain. Their goal is to leverage emerging stem cell technologies to better understand neurological disease and develop novel tools for the discovery of disease mechanisms and treatment.


Stem Cell & Gene Therapy

  • Martin Andrews

    Keynote Speaker

    Martin Andrews, Senior VP, GSK Rare Diseases

    Glaxo Smith Kline

    A Biology graduate, Martin joined the Pharmaceutical Industry in 1985 as a trainee with Beecham Group Plc.  He has followed a broad Commercial career path working across numerous therapy areas in country, regional and global positions embracing new product development, commercial strategy and significant operational leadership roles including. In his current role Martin leads an integrated unit comprising R&D, Medical, Scientific and Commercial support. GSK’s Rare Disease medicines portfolio includes marketed medicines for PAH, and medicines in development for Amyloidosis and Gene Therapy. 

  • Nadia Rosenthal, PhD

    Keynote Speaker

    Nadia Rosenthal, PhD

    Australian Regenerative Medicine Institute

    Professor Nadia Rosenthal is Founding Director of the Australian Regenerative Medicine Institute in Melbourne and Scientific Head of EMBL Australia. Her research focuses on the role of growth factors, stem cells, and the immune system in regenerative medicine.  She was awarded the Ferrari-Soave Prize, Doctors Honoris Causa from the Pierre and Marie Curie University in Paris and the University of Amsterdam, and an NH&MRC Australia Fellowship. She is an EMBO member and a Fellow of the Academy of Medical Sciences, UK.


  • Maria Grazia-Roncarolo, MD


    Maria Grazia Roncarolo, MD

    Stanford/Pediatrics/Translational and Regenerative Medicine

    Dr. Roncarolo is a Professor of Pediatrics and Medicine at Stanford School of Medicine, Chief of the Division of Pediatric Stem Cell Transplantation and Regenerative Medicine, Co-Director of the Bass Center for Childhood Blood Disease and Co-Director of the Institute for Stem Cell Biology and Regenerative Medicine.  Her efforts focus on the translation of scientific discoveries in genetic diseases and regenerative medicine into novel patient therapies, including treatments based on stem cells and gene therapy.

  • Hiro Nakauchi, MD, PhD

    Hiro Nakauchi, MD, PhD

    Stanford/Genetics & Univ of Tokyo/Dir of Stem Cell Regen Med

    Dr. Nakauchi is a leader and pioneer in stem cell therapy, who was previously Professor of Stem Cell and Director of the Center for Stem Cell Biology and Regenerative Medicine at Institute of Medical Science at The University of Tokyo and recently Professor at the Institute of Stem Cell Biology and Regenerative Medicine at Stanford University. Goals of his work are to translate discoveries in basic research into practical medical applications.

  • Tony Oro, PhD

    Tony Oro, MD, PhD

    Stanford/Dermatology/Pediatric Dermatology

    Dr. Oro is a Professor in the Stanford Dermatology Department and member of the Institute for Stem Cell Biology and Regenerative Medicine and the Cancer Institute. He is a practicing dermatologist interested in epithelial regeneration and carcinogenesis. He helped discover the link between the hedgehog pathway and human cancer and studies how tumors evolve during treatment. He has helped developed the use of corrected induced pluripotent cells for tissue regeneration in childhood diseases like epidermolysis bullosa.

  • Matt Porteus, MD, PhD

    Matt Porteus, MD, PhD

    Stanford/Pediatrics/Stem Cell Transplant

    Dr. Porteus is Associate Professor in Pediatrics at Stanford Medical School and an attending physician at the Lucille Packard Children’s Hospital, where he cares for pediatric patients undergoing hematopoietic stem cell transplantation. He was the first to demonstrate that gene correction could be achieved in human cells at frequencies that were high enough to cure patients and is considered one of the pioneers and founders of the field of genome editing - a field that now encompasses thousands of labs and several new companies throughout the world.

  • Sean Wu, MD, PhD

    Sean Wu, MD, PhD


    Dr. Wu is Assistant Professor of Medicine and Pediatrics (by courtesy) and studies the mechanisms that regulate heart formation during embryonic development. He is focused on developing new therapies for treating children and adults with heart failure due to congenital heart malformation and heart injury. His laboratory has pioneered the use of stem cells to understand the process of heart development and to generate artificial hearts by tissue engineering.

Accelerating Innovation

  • Alan Greene, MD, FAACP

    Keynote Speaker

    Alan Greene, MD, FAACP

    Renowned practicing pediatrician Alan Greene, MD, is a leading authority on child health and wellness. He is the author of several books including Raising Baby Green and Feeding Baby Green. He appears frequently in the media including The TODAY Show, Good Morning America and The Dr. Oz Show. He is the founder of the pioneering Web site, and was named the Children’s Health Hero of the Internet by Intel.


  • Dennis P. Wall, PhD


    Dennis P. Wall, PhD

    Stanford Medicine/Pediatrics

    Dr. Wall is Associate Professor in the Department of Pediatrics and Division of Systems Medicine at Stanford University, where his lab is developing novel approaches in systems biology to decipher the molecular pathology of autism spectrum disorder and related neurological conditions. Dr. Wall has acted as science advisor to several biotechnology and pharmaceutical companies, has created and advised on cutting-edge approaches to cloud computing, and has received numerous awards, including the Harvard Medical School Leadership Award and the Slifka/Ritvo Clinical Innovation in Autism Research Award for outstanding advancements in clinical translation.

  • Dana Cho

    Dana Cho, MA


    Dana Cho is a Partner at IDEO, Palo Alto, and serves as the Executive Director of IDEO’s Health and Life Sciences portfolio. She is passionate about bringing Design Thinking to bear on the cutting edge of health innovation. 

  • craiggarner

    Craig Garner, PhD


    Dr. Garner is Professor in the Department of Psychiatry and Behavioral Sciences and the co-director of the Center for Research and Treatment of Down Syndrome at Stanford University. Dr. Garner is a developmental neurobiologist interested in how environmental and genetic insults to the developing nervous system impair cognitive function in neurodevelopmental disorders such as Down syndrome, autism and fragile X syndrome.

  • rosen

    Daria Mochly-Rosen, PhD

    Stanford/Chemical and Systems Biology

    Dr. Daria Mochly-Rosen is a Professor in Chemical and Systems Biology and the George D. Smith Professor for Translational Medicine at Stanford University School of Medicine. She leads a multi-disciplinary research lab that includes chemists, biochemists, biologists, and physician scientists and has used her basic research discoveries to develop a number of drug leads for human diseases with a particular interest in mitochondrial biology and pathology. She has published over 200 papers and over 30 patents and patent applications.

  • shreyasvasanawala

    Shreyas Vasanawala, MD, PhD

    Stanford/Radiology/Pediatric Radiology

    Dr. Vasanawala's group is focused on developing new MRI techniques, and in particular, developing novel applications for children. They take a comprehensive approach, exploring novel hardware, MRI pulse sequence techniques, and motion correction methods. These approaches are then evaluated for cardiovascular, abdominal, and musculoskeletal pediatric MRI exams. Additionally, they seek to develop quantitative MRI methods, including those for cardiovascular function, renal function, and tumor perfusion.

Precision Medicine

  • Euan Ashley, MD

    Keynote Speaker

    Euan Ashley, MD


    Dr. Ashley is focused on the application of whole genome sequencing to the medical care of individuals and families. He leads the Stanford Center for Inherited Cardiovascular Disease, one of the few medical centers in the country where patient genome sequences can be readily incorporated into clinical care. In 2010, Dr. Ashley led the team that completed the first clinical interpretation of a human genome and has since extended this to a pipeline that handles families in 2011. 

  • Julien Sage, PhD


    Julien Sage, PhD

    Stanford/Pediatrics/Cancer Biology

    Dr. Sage is Associate Professor of Pediatrics and Genetics at Stanford. He trained at the École Normale Supérieure in Paris, the Pasteur Institute, and at the University of Nice, France. As a post-doctoral fellow in the laboratory of Dr. Tyler Jacks at MIT, Dr. Sage developed an interest in in vivo models to study cancer, including pediatric tumors. In the last ten years at Stanford University, his laboratory has investigated the differences and the similarities between "normal" cells, cancer cells, and stem cells. Pre-clinical studies in the Sage lab have led to clinical trials in cancer patients.

  • Atul Butte, MD, PhD

    Atul Butte, MD, PhD

    Director/Institute for Computational Health Sciences/UCSF

    Atul leads the new UCSF Institute for Computational Health Sciences, effective April 1, 2015. In addition to his role at UCSF, Atul also has been named executive director of clinical informatics for UC Health Sciences and Services, which is developing and implementing a UC-wide data warehouse and analytic platform. Previously, Atul was Chief of the Division of Systems Medicine and Associate Professor of Pediatrics at Stanford University. His research laboratory focuses on building and applying computational tools to convert hundreds of trillions of points of molecular, clinical and epidemiological data collected by researchers worldwide over the past decade, into new diagnostics, therapeutics and insights into both rare and common diseases.

  • Ricardo Dolmetsch, PhD

    Ricardo Dolmetsch, PhD


    Dr. Dolmetsch is Global Head of Neuroscience at the Novartis Institutes for BioMedical Research where his group leverages advances in human genetics to model and treat neuropsychiatric and neurodegenerative diseases. Areas of focus include genomics, induced pluripotent stem cells, and brain circuitry.

  • Imran Haque, PhD

    Imran Haque, PhD

    Counsyl/pre-natal genetic testing

    Dr. Haque is the Director of Research at Counsyl, where he focuses on data sharing for large-scale clinical testing and development of advanced genomics technologies. Prior to Counsyl, Dr. Haque completed his PhD in computer science at Stanford University, where he worked with Vijay Pande and Daphne Koller on large-scale machine learning methods for computational drug discovery.

  • Matt Wilsey

    Matt Wilsey

    Grace Wilsey Foundation

    Matt is an entrepreneur, investor, and advisor. In addition to consumer services, Matt invests in and advocates for medical research, drug discovery, and NGS technologies. He became a rare disease hunter after his child was born with NGLY1 Deficiency. He has since funded 50+ scientists at 10 centers. Matt holds a B.A. and M.B.A. from Stanford and sits on the Board of Directors of the Grace Wilsey Foundation, Global Genes, The Lucile Packard Foundation for Children’s Health, the EveryLife Foundation, and Perlstein Lab.

Health Ecosystem

  • Donald Schwarz, MD, MPH, MBA

    Keynote Speaker

    Donald Schwarz, MD, MPH, MBA

    RWJF Director

    Dr. Schwarz leads the Robert Wood Johnson Foundation's (RWJF) efforts to promote healthier places in which we can live, learn, work, and play, as well as the effort to identify, support, and spread the word about policies and approaches that promote lifelong health for all Americans. A distinguished leader in public health, and former deputy mayor for the City of Philadelphia, he joined the Foundation in July 2014 after a long career in academic pediatrics at the University of Pennsylvania and The Children's Hospital of Philadelphia.

  • Tom Robinson, MD, MPH


    Thomas Robinson, MD, MPH

    Stanford/Pediatrics/General Pediatrics

    Dr. Robinson is the Irving Schulman, M.D. Endowed Professor of Child Health, Professor of Pediatrics and of Medicine, Director of the Stanford Solutions Science Lab, and Director of the Center for Healthy Weight at Stanford University and Lucile Packard Children’s Hospital Stanford. Dr. Robinson is known for his pioneering solution-oriented research to maximize health and well-being in all children and families. He introduced the concept of stealth interventions to prevent obesity, improve nutrition, increase physical activity, reduce smoking, limit screen time and promote environmental sustainability.

  • Geoffrey Cohen, PhD

    Geoffrey Cohen, PhD


    Dr. Cohen is Professor of Organizational Studies in Education and Business at Stanford and focused on processes related to identity maintenance and their implications for social problems. One primary aim of his research is the development of theory-driven, rigorously tested intervention strategies that further our understanding of the processes underpinning social problems and that offer solutions to alleviate them. His work is also focused on how and when seemingly brief interventions, attuned to underlying psychological processes, produce large and long-lasting psychological and behavioral change.

  • Gary Darmstadt, MD, PhD

    Gary Darmstadt, MD, PhD

    Stanford Medicine/Pediatrics/Neonatology

    Dr. Gary Darmstadt is Associate Dean for Maternal and Child Health, and Professor of Pediatrics in the Division of Neonatal and Developmental Pediatrics at the Stanford University School of Medicine. Previously Dr. Darmstadt was Senior Fellow at the Bill & Melinda Gates Foundation, where he developed initiatives to address gender inequalities, empower women and girls, and improve health and development outcomes. Prior to this role, he served as the Gates Foundation Director of Family Health, leading strategy development and implementation across nutrition, family planning and maternal, newborn and child health.

    Dr. Darmstadt was formerly Associate Professor and Founding Director of the International Center for Advancing Neonatal Health in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health. He also served as Senior Research Advisor for the Saving Newborn Lives program of Save the Children-US, where he led the development and implementation of the global research strategy for newborn health and survival, before joining Johns Hopkins. Dr. Darmstadt trained in Medicine (MD) at the University of California, San Diego, in Pediatrics at Johns Hopkins University, in Dermatology at Stanford University, and in Pediatric Infectious Disease as a fellow at the University of Washington, Seattle.

  • Anne Fernald, PhD

    Anne Fernald, PhD


    Dr. Fernald, the Josephine Knotts Knowles Professor of Human Biology, heads the Language Learning Lab in the Department of Psychology.   Working with rich and poor families with infants in the U.S and in West Africa, Fernald's work reveals that engaging infants with language in daily interactions is crucial for strengthening their speech processing and vocabulary learning. A central goal of this research is to show how parents from diverse sociocultural backgrounds play a vital role in supporting their children’s language and cognitive development.

  • Paul Wise, MD, MPH

    Paul Wise, MD, MPH


    Dr. Wise is the Richard E. Behrman Professor of Child Health and Society, Professor of Pediatrics, and Senior Fellow in the Freeman-Spogli Institute for International Studies, Stanford University. He is a core faculty member of the Center for Policy, Outcomes and Prevention and the Centers for Health Policy and Primary Care Outcomes Research. Dr. Wise’s research focuses on health inequalities, child health policy, and health care delivery in areas of poor governance and political instability.